Insiders Editas Medicine, Inc.

Equities

EDIT

US28106W1036

Real-time Estimate Cboe BZX Other stock markets 18:25:13 10/05/2024 BST			5-day change	1st Jan Change
5.345 ^USD	-3.87%		-5.20%	-46.94%

05-09	Barclays Adjusts Editas Medicine Price Target to $9 From $11, Maintains Equal Weight Rating	MT
05-09	Morgan Stanley Upgrades Editas Medicine to Equal-Weight From Underweight	MT

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Editas Medicine, Inc. Announces Bruce E. Eaton Will Step Down as Chief Technology Officer and Chief Business Officer, Effective January 2, 2024	10/10/23	CI
Editas Medicine, Inc. Appoints Caren Deardorf as Chief Commercial and Strategy Officer	25/09/23	CI
Geron Appoints Michelle Robertson as Chief Financial Officer	11/09/23	MT
Editas Medicine, Inc. Announces Appointment of Linda C. Burkly as Executive Vice President and Chief Scientific Officer	24/07/23	CI
Editas Medicine Names Erick Lucera CFO	16/05/23	MT
Editas Medicine, Inc. Announces Management Changes	15/05/23	CI
Editas Medicine, Inc. Appoints Elliot Levy, M.D. as an Independent Director, Effective Immediately	13/04/23	CI
Editas Medicine, Inc. Announces That James C. Mullen, the Executive Chairman of the Board of Directors Will Not Stand for Re-Election as A Director	14/03/23	CI
Editas Medicine, Inc. Announces the Appointment of Linea Aspesi as Executive Vice President and Chief People Officer	08/03/23	CI
Editas Medicine, Inc. Announces Step Down of Mark S. Shearman as Executive Vice President and Chief Scientific Officer, Effective March 31, 2023	09/01/23	CI
Editas Medicine Appoints Baisong Mei, as Chief Medical Officer	18/07/22	CI
Editas Medicine Appoints Sarepta Therapeutics Executive Gilmore O'Neill as CEO	14/04/22	MT
Editas Medicine, Inc. Announces Executive Changes, Effective June 1, 2022	14/04/22	CI
Editas Medicine, Inc. Appoints Gilmore O’Neill as Chief Executive Officer, Effective June 1, 2022	14/04/22	CI
Editas Medicine Terminates Employment of Chief Medical Officer	08/02/22	MT
Editas Medicine, Inc. Terminates Lisa Michaels as Chief Medical Officer	07/02/22	CI
Editas Medicine Names Bernadette Connaughton to Board of Directors	28/10/21	CI
Insider Sell: Editas Medicine	20/10/21	MT
Editas Medicine, Inc. Names Emma Reeve to Board of Directors	08/09/21	CI
Editas Medicine, Inc. Announces Executive Changes	26/07/21	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Editas Medicine, Inc.

Equities

EDIT

US28106W1036

Insiders

Filters